Search Results - "Martinez de Villareal, J."

1231P Phase I study to evaluate the safety, tolerability, and efficacy of VCN-01 in combination with durvalumab (MEDI4736) in subjects with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC) by Jove, M., Brana, I., Oliva Bernal, M., Hernando-Calvo, A., Erasun Lecuona, C., Assaf Pastrana, J.D., Bazan Peregrino, M., Mato-Berciano, A., Maliandi, M.V., Torres-Manjon, S., Martinez de Villareal, J., Real, F.X., Nuciforo, P.G., Alemany, R., Capella, G., Blasi, E., Blasco, C., Cascallo Piqueras, M., Mesia Nin, R.

Get full text

STAG2 and PPARg as drivers of luminal-type bladder cancer by Lapi, E, Kalisz, M, Martínez de, Villareal J, Santos, C, Sjödahl, G, Dyrskjøt, L, Höglund, M, Losada, A, Real, FX

“…Several groups, including ours, have identified STAG2 as a new bladder tumor suppressor gene. STAG2 is part of cohesin, a complex involved in chromosome…”
Get full text